Amelioration of negative symptoms in schizophrenia by glycine

Publisher Website
Google Scholar
Abstract
Phencyclidine induces a psychotomimetic state by blocking neurotransmission at N-methyl-D-aspartic acid (NMDA) receptors. In a double-blind, placebo-controlled fashion, 14 medicated patients with chronic schizophrenia were treated with glycine, a potentiator of NMDA- receptor-mediated neurotransmission. Significant improvement in negative symptoms occurred in the group given glycine but not in the group given placebo, suggesting that potentiation of NMDA-receptor- mediated neurotransmission may represent an effective treatment for neuroleptic-resistant negative symptoms in schizophrenia.

This publication has 9 references indexed in Scilit: